The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     
Free Stock Picks by Top Performers
SocialPicks is a community where stock investors exchange ideas and track performance of financial bloggers.
Top_member_photos
Get free stock picks and email alerts daily
 
Are you a stock guru?

 sudipbanerjee     Graphic_subscribe   

    Start Tracking sudipbanerjee  -  Add to Friends  -  Send Message   
    Community Rank: Analyst (134 pts)  |  Member since 06/26/2009
Picks Performance:
N/A

No percentile ranking
has been calculated.

What's this?
All-time Return
+107.70%
(in 4 months) 		Risk (SD)
Conservative
0.00% 		Sharpe Ratio
N/A
Followers
0 		Winning Picks
1 of 1 		Total Views
3055


 Last Activity: Added TTHI to bullish list on 06/26/09 

Current Stock List:
Symbol SP Sentiment Rating Return Since
TTHI N/A Positive +107.70% 06/26/09




Discussions

Upcoming FDA Panel decision on Biotech company's stress a... 07/22/09
FDA Panel to review King Pharma's (KG) stress agent drug Corvue on July 28th. If they get a favorable backing by the panel, the chances of approval by the FDA will increase significantly. If Corvue gets approved bythe FDA, it is estimated to achieve Peak sales of $350 million. To read about our expectation on the Panel decision, how the drug and the disease work, and the potential impact of...

FDA is going to decide on the approval of new Gout drug 07/16/09
An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. This FDA decision will affect (competitor stock symbol) directly since they also have a Gout drug in development. To read about whether this small cap company has chances to get their drug approved, get a FREE report at: http://www.newbiomedicine.com

FDA is going to decide on the approval of new Gout drug 07/16/09
Krystexxa for the treatment of Gout will face the FDA decision on the approval of the drug shortly. Gout has traditionally been a difficult disease to treat. To read about our opinion on SVNT's chances of getting approval on the drug, get a FREE report at: http://www.newbiomedicine.com

A small cap company’s upcoming Phase 2 Alzheimer's drug d... 07/13/09
TTHI is going to be presenting data on their Alzheimer's disease drug (ELND-005) at the Alzheimer's conference this week. If the trials data is positive, it brings the company one step closer to the approval of their breakthrough treatment for Alzheimer's disease. To find out about the drug, how the drug works, who are the other players developing drugs in this area and how TTHI's drug compar...

A small cap company's upcoming Phase 2 arthritis drug dat... 07/09/09
RIGL will be presenting data on its arthritis drug (R788) on July 9th (Thursday). If the trial' data is positive, it brings the company one step closer to the approval of a promising treatment for arthritis. Given the size of the arthritis disease market, this could result in a significant movement in the stock either ways depending on the result. To read about our opinion on whether the res...

Upcoming FDA decision on small cap company's Pain drug on... 07/06/09
Upcoming FDA decision on a small cap company's drug for Pain expected on July 10th. The decision was expected on June 12th but FDA pushed back the decision. If the FDA approves this drug, it will compete directly with (stock symbol). To read about our opinion on whether the drug will be approved or not, along with details of the company, the drug, the disease, the other player in this area, th...

Upcoming FDA decision on small cap company's Pain drug on... 07/06/09
Upcoming FDA decision on a BDSI's drug Onsolis for Pain is expected on July 10th. The decision was expected on June 12th but FDA pushed back the decision. To read about our opinion on whether Onsolis will be approved or not, along with details of the drug, the disease, the other player in this area, the market and the sales potential of the drug (if approved), get a FREE report at: http://www...

Upcoming FDA Decision on June 29th on approval of a small... 06/27/09
The upcoming FDA Decision date on JUNE 29th (Monday) for AMAG's Feraheme for iron deficiency in Anemia patients is a critical event for the company. If the FDA approves this drug, it could become the gold standard for iron deficiency in anemic patients who have chronic kidney disease. To read about our opinion on whether Feraheme will be approved or not, along with details of the company, the...

Upcoming Clinical Trials data of a small cap company's Al... 06/26/09
A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. The results of this clinical trial data will directly affect MDVN, PFE, EPIX, GSK, WYE and PRAN because they are direct competitors in this area. To find out to what extent it will affect these companies and to get detailed information about the small cap company, the drug, how ...

Upcoming Clinical Trials data of a small cap company's Al... 06/26/09
A small cap company is going to be presenting data on their Alzheimer's drug at the Alzheimer's conference in July. The results of this clinical trial data will directly affect MDVN, PFE, EPIX, GSK, WYE and PRAN because they are direct competitors in this area. To find out to what extent it will affect these companies and to get detailed information about the small cap company, the drug, how ...




People Following sudipbanerjee ...

Nobody is following sudipbanerjee.



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 377
2 Gerald Greene 18.14 +70.10% 208
3 stockmarketfunding.com 17.66 +25.70% 55
4 akiralegrand 13.47 +14.32% 61
5 anup2104 12.13 +75.30% 38


POPULAR STOCKS
Symbol Company Name Sentiment
BA The Boeing Company
INTC Intel Corp
T AT&T Inc
WFC Wells Fargo & Company
FSLR First Solar Inc.
EBAY eBay Inc

TODAY'S HEADLINES

TODAY'S TOP PICKS

 
Similarity to Me   ?

Compare Your Portfolio With sudipbanerjee:
Enter stocks you like & track your performance:

Symbols, separated by space (e.g. AAPL GOOG MSFT)



More about sudipbanerjee

Avg exp holding time:
148.00 days



Similar Portfolios
Zacks.com (zacks.com) 28% 100%
tanumoy (tanumoy) N/A 100%
kickmyknee (kickmyknee) N/A 100%



IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch